Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)

Press Releases

We are keeping you informed! If you have questions regarding our press releases, feel free to contact us via the website´s contact form. Stay up-to-date with our companies latest news:

Eckert & Ziegler BEBIG: First Half-Year Results 2014 Published

Seneffe - Belgium, August 5th, 2014, Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) has announced today the publication of its report on the first half-year results 2014. The report including a selection of consolidated key figures for the six months ending June 30th, 2014 can be downloaded at: > Investor Relations > Financial Reports

Eckert & Ziegler BEBIG
...Contributing to saving lives!

Eckert & Ziegler BEBIG, incorporated in 1996, is a European-based company active in the medical device segment of the health care industry.

Eckert & Ziegler BEBIG's core business is the treatment of cancer using brachytherapy, a special form of radiation therapy.

Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters are in Belgium, with a production facility in both Germany and the USA and subsidiaries throughout Europe as well as in India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing of its product line.

The company's products and equipment are intended for use by oncologists, radiologists, urologists, and medical physicists. Eckert & Ziegler BEBIG employs more than 200 people. The company has been listed on the NYSE Euronext Brussels stock exchange since April 1997 (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB).


Eckert & Ziegler BEBIG s.a.
Investor Relations
Tel.: +32 (0) 64 520 808